Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 13, 2025 04:18 ET | Source: Research and Markets

Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight Report, 2025 - Featuring Analysis of Inventiva Pharma, Cirius Therapeutics, Terns Pharmaceuticals, HighTide Biopharma, Eli Lilly and Company, and More

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
May 02, 2024 07:25 ET | Source: Research and Markets

Non-Alcoholic Steatohepatitis (NASH) Pipeline Insight, 2024 Featuring 100+ Companies and 110+ Pipeline Drugs Including Lanifibranor (Inventiva Pharma), MSDC-0602K (Cirius Therapeutics), TERN-501 (Terns Pharma)

Dublin, May 02, 2024 (GLOBE NEWSWIRE) -- The "Non-Alcoholic Steatohepatitis (NASH) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides...
November 10, 2023 08:23 ET | Source: Research and Markets

Challenges in Non-Alcoholic Steatohepatitis (NASH) Diagnosis and Lack of Definitive Methods Hamper Market Growth Despite Rising Awareness

Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market (by Drug Type, Application Type, Distribution Type, & Region): Insights and Forecast with Potential...
September 28, 2023 06:03 ET | Source: Research and Markets

Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market 2023-2035: Key Players Pfizer, Novo Nordisk, and Galmed Pharmaceuticals Drive Innovation in the NASH Therapeutics Market

Dublin, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The "Global Nonalcoholic Steatohepatitis (NASH) Therapeutics Market Outlook to 2035" report has been added to ResearchAndMarkets.com's offering. The...
January 09, 2023 04:23 ET | Source: Research and Markets

Global Non-Alcoholic Steatohepatitis Market Report to 2027 - Featuring Intercept Pharmaceuticals, Novartis, Siemens Healthineers and AstraZeneca Among Others

Dublin, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis Market: Analysis By Drug Type, By Application Type, By Distribution Type, By Region Size and Trends with Impact of...
May 05, 2021 04:43 ET | Source: Research and Markets

Insights on the Non-Alcoholic Steatohepatitis (NASH) Biomarker Global Market to 2028 - by Type, Industry Verticals and Region

Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Global Non-Alcoholic Steatohepatitis (NASH) Biomarker Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. According to this...
April 13, 2021 07:13 ET | Source: Research and Markets

Global NASH Market Report 2021: Market was Valued at $3,369.12 Million in 2020 - Forecast to 2026

Dublin, April 13, 2021 (GLOBE NEWSWIRE) -- The "Global NASH Market - Analysis By Drug Type, Sales Chanel, By Region, By Country (2021 Edition): Market Insights, Covid-19 Impact, Competition and...
March 23, 2021 08:08 ET | Source: Research and Markets

Global Non-alcoholic Steatohepatitis (NASH) Market 2021-2038: Increased Competition from New Product Launches will Shape the NASH Market

Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Non-alcoholic steatohepatitis (NASH) Market and Forecast Analysis to 2038" report has been added to ResearchAndMarkets.com's offering. There are...